Cargando…
Comparison of Intralesional Measles, Mumps, Rubella Vaccine and Needling in the Treatment of Recurrent Warts
CONTEXT: Warts constitute 21% of all the cases in a dermatology clinic. Their causative agent is the human papillomavirus (HPV). Most of the cutaneous warts are cosmetically disfiguring and their treatment requires patience by both the practitioner and the patients. AIM: This study aimed to compare...
Autores principales: | Kolte, Surabhi R., Sardesai, Vidyadhar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646425/ https://www.ncbi.nlm.nih.gov/pubmed/33208998 http://dx.doi.org/10.4103/JCAS.JCAS_164_19 |
Ejemplares similares
-
Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
por: Zamanian, Abbas, et al.
Publicado: (2014) -
Why Intralesional Measles-Mumps-Rubella is Superior to Bacillus Calmette-Guérin for Treatment of Warts?
por: Al-Qassabi, Al Mutasim, et al.
Publicado: (2022) -
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022) -
The Efficacy and Safety of Intralesional Immunotherapy with Measles, Mumps, Rubella Virus Vaccine for the Treatment of Common Warts in Adults
por: Chauhan, Pushpinder Singh, et al.
Publicado: (2019) -
Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial
por: Rezai, Mohammad Sadegh, et al.
Publicado: (2019)